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ABSTRACT
Background: Although reactive oxygen species (ROS) are believed to be in-
volved in pathogenic mechanisms that underlie complex regional pain syndrome type I
(CRPS-I), the role of ROS in the central mechanism of CRPS is not fully understood.
Objective: In this study we investigated whether ROS scavenger N-acetyl-L-
cysteine (NAC) was capable of attenuating mechanical allodynia and whether pain was
decreased through modulating N-methyl-D-aspartate (NMDA) receptor activation in a
hronic postischemia pain (CPIP) animal model that mimics the symptoms of CRPS-I.
Methods: Thirty male Sprague-Dawley rats were randomly allocated to 5
different groups: (1) sham rats and CPIP rats treated with (2) vehicle; (3) NAC 30
mg/kg; (4) NAC 100 mg/kg; and (5) NAC 300 mg/kg intraperitoneally at 15
minutes before reperfusion. CPIP was generated after a 3-hour ischemia/reperfusion
injury on the hind limb using a tight fitting O-ring. Then, mechanical paw-
withdrawal thresholds to von Frey stimuli were assessed before ischemia (baseline), at
4 hours; 1, 3, and 5 days; and 1, 2, 3, and 4 weeks after reperfusion. Another set of
5 animal groups in the same categories was used to determine phosphorylated NMDA
receptor 1 subunit (pNR1) immunoreactivity in the ipsilateral L4/6 spinal cord at 3
days after reperfusion.
Results: The sham group showed no significant difference in pain thresholds
ver 4 weeks. With NAC treatment, the pain thresholds measured after reperfusion
ncreased significantly, and this increase lasted 4 weeks after reperfusion compared
ith the vehicle group (P  0.01 on the ipsilateral side and P  0.05 on the
ontralateral side). The relative density of pNR1 at 3 days after reperfusion in
AC-treated rats decreased significantly compared with that of the vehicle group (all,
 0.001). The NAC dose was significantly correlated not only with paw-with-
drawal threshold (  0.979; P  0.001) but also with the relative density of pNR1
  –0.875; P  0.001).
Conclusions: NAC, administered during the pre-reperfusion period, had a
ong-term antiallodynic effect through the attenuation of NMDA receptor phosphor-
Accepted for publication August 10, 2011. doi:10.1016/j.curtheres.2011.08.001
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K.-H. Kwak et al.ylation, leading to central sensitization. (Curr Ther Res Clin Exp. 2011;72:216–227)
© 2011 Elsevier HS Journals, Inc. All rights reserved.
Key words: central sensitization, ischemia/reperfusion injury, NAC, NMDA
eceptor activation, pain, reactive oxygen species.
INTRODUCTION
Complex regional pain syndrome (CRPS) is a chronic pain disorder with significant
autonomic features; it typically develops in an extremity after tissue injury. In type
I CRPS (CRPS-I), there is no obvious nerve injury. CRPS is one of the most
challenging chronic pain conditions to treat successfully because of the incomplete
understanding of its pathophysiologic mechanism(s).1
Consistent with growing evidence suggesting that oxygen free radicals may con-
ribute to chronic pain, including neuropathic and inflammatory pain, several studies
ave reported that reactive oxygen species (ROS) are believed to be involved in the
athogenesis of CRPS. Serum lipid peroxidation products and salivary antioxidants,
nown to be induced by ROS, are increased in CRPS-I patients.2 CRPS-I symptoms
re relieved after treatment with free-radical scavengers,3,4 and the incidence or
uration of CRPS-I after wrist fractures may be reduced by preemptive treatment
ith the antioxidant, vitamin C.5,6
However, although these studies suggested the involvement of free radicals and/or
xidative stress in CRPS, little attention has been paid to the role of antioxidants in
he central mechanism(s) of CRPS. Central nervous system plasticity in response to
issue injury may contribute to the development of chronic pain. It is well known that
he N-methyl-D-aspartate (NMDA) receptor is important for the development of
central sensitization in the dorsal horn.7–9 Thus, phosphorylation of the NMDA
receptor is an important component in receptor facilitation, probably contributing to
central sensitization as a basis for chronic pain.10–13
N-acetyl-L-cysteine (NAC) is a well-known and powerful antioxidant that has been
sed widely clinically as a mucolytic agent and as an antidote for paracetamol
acetaminophen) poisoning. In neurons, glutathione is important in preventing
xidative stress. By acting as a cysteine donor, NAC maintains the intracellular
lutathione level and plays a neuroprotective role for a range of neuronal cell types
gainst diverse stimuli.14 NAC has been reported to attenuate a significant reduction
in hyperalgesia in chronic constriction injury-induced neuropathic rats.15 Also,
ystemic NAC administration reduced the nociception triggered by intrathecal in-
ection of capsaicin, indicating a role in nociception at the level of the spinal cord.16
Thus, in the present study, we sought to evaluate the role of NAC in the central
ensitization involved in the pathophysiology of CRPS. Specifically, we focused on the
reventative role of NAC in modifying central neuroplastic changes. To test the
ypothesis, we used chronic postischemia pain (CPIP) rats as reported by Coderre
t al.17 Their initial report showed that 3-hour ischemia/reperfusion (IR) of the hind
paw of CPIP rats induced long-term mechanical allodynia or CPIP, which was similar
to the clinical features seen in patients with CRPS-I.17 In the present study, we
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Current Therapeutic Researchinvestigated the antiallodynic effects of NAC administered before reperfusion in
IR-induced CPIP rats and examined changes in the level of phosphorylated NMDA
receptor 1 subunit (pNR1), which presumably indicates central sensitization, in the
spinal dorsal horn of the CPIP model rats.
METHODS
Animals
Male adult Sprague-Dawley rats (280–320 g) were used in this study. Animals
ere housed in groups, with food and water available ad libitum, on a 12:12 hour
ight:dark cycle. All animals were acclimated in their cages for 7 days before any
xperiments. All housing conditions and experimental procedures were approved by
he Institutional Animal Care and Use Committee and in accordance with the
ational Institute of Health guidelines on laboratory animal welfare.
All rats were assessed for posture and righting reflexes based on the 5-point scales
escribed by Kim et al,18 and all scored zero at all time points, showing that sedation
or anesthesia did not occur.1
Hind Paw Ischemia/Reperfusion and Drug Treatment
Hind paw IR injury was produced according to Coderre et al17 In brief, rats were
nesthetized over a 3-hour period with a sodium pentobarbital infusion. After
nduction of anesthesia, a Nitrile 70 Durometer O-ring (O-rings West, Seattle,
ashington) with 7/32 inch internal diameter was placed around the rat’s left hind
imb just proximal to the ankle joint. The termination of sodium pentobarbital
nesthesia was timed so that rats recovered fully within 30 minutes after reperfusion,
hich occurred immediately after removal of the O-ring. Sham rats received exactly
he same treatment, except that the O-ring was cut so that it only loosely surrounded
he ankle, and did not occlude blood flow to the hind paw.
xperiment I
To determine the effects of ROS scavengers on CPIP-induced mechanical allodynia
nd the dose response of a ROS scavenger, NAC, dissolved in luke warm normal
aline (300 mg/mL, which was further diluted to 30 and 100 mg/mL) was admin-
stered intraperitoneally 15 minutes before reperfusion to rats with CPIP at 30, 100,
nd 300 mg/kg doses. Thirty male Sprague-Dawley rats were randomly allocated to
different groups: (1) sham rats and CPIP rats treated with (2) vehicle; (3) NAC 30
g/kg; (4) NAC 100 mg/kg; and (5) NAC 300 mg/kg intraperitoneally at 15
inutes before reperfusion. The pain withdrawal threshold in mechanical allodynia
as measured at different time intervals (before ischemia [baseline]; at 4 hours; at 1,
, and 5 days; and at 1, 2, 3, and 4 weeks after reperfusion). The changes in the pain
hreshold in test groups were compared with that of sham- or vehicle-treated control
ats. The whole procedures were conducted blindly, in that the experimenter did not
now the nature of experimental manipulation.
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K.-H. Kwak et al.Experiment II
To evaluate the role of NAC on the phosphorylation of NMDA receptors, another
set of 5 animal groups consisting of 6 for each group was used: (1) sham rats and CPIP
rats treated with (2) vehicle; (3) NAC 30 mg/kg; (4) NAC 100 mg/kg; and (5) NAC
300 mg/kg intraperitoneally at 15 minutes before reperfusion. Three days after
reperfusion, pNR1 immunoreactivity was determined in the ipsilateral L4/6 spinal
cord by Western blot after measuring the development of mechanical allodynia,
which was assessed before ischemia and at 3 days after reperfusion.
Behavioral Test
Hind paw mechanical thresholds were assessed by measuring the withdrawal response
o von Frey filament stimulation according to a modification of the up/down method
escribed by Chaplan et al.19,20 In brief, rats were placed on a metal mesh floor covered
with an inverted clear plastic cage (15  23  24 cm3) through which the von Frey
laments (nylon monofilaments; Stoelting, Woodale, Illinois) were applied to the plantar
urface of the hind paw. Filaments were applied in either ascending or descending
trength as necessary to determine the filament closest to the threshold of response. Each
lament was applied once for 10 seconds to the center of the paw between the pads and
lower intensity hair after each positive response, whereas a higher intensity hair followed
ach negative response (until 6 responses were recorded after a first change in response).
he minimum stimulus intensity was 0.25 g and the maximum was 15 g. Based on the
esponse pattern and the force of the final filament, the 50% response threshold (grams)
as calculated. The resulting pattern of positive and negative responses was
abulated, and the 50% response threshold was interpolated using the formula
0% g threshold  (10[xf  k])/10,000, where xf  the value (in log units) of the
final von Frey hair used; k  tabular value19 for pattern of positive/negative
responses; and   mean difference (in log units) between stimuli (here, 0.224).
Western Blot
To examine the levels of activated NMDA receptors in the dorsal horn, rats were
acrificed immediately after behavioral testing at 3 days after reperfusion. At the time of
acrifice, rats were anesthetized using sodium pentobarbital (50 mg/kg IP) and then
erfused quickly through the ascending aorta with cold saline. The L4/6 spinal cord
egments (ipsilateral and contralateral sides, separately) were quickly removed, frozen
mmediately on dry ice, and stored at70°C until use. At the time of assay, each spinal
ord sample was thawed and homogenized in a lysis buffer (20 mM Tris-hyrdocholoride
H 8.0, 150 mM sodium chloride 1 mM EDTA, 2 mM sodium orthovanadate, 0.5 mM
ithiothreitol, 10% glycerol, 1% Nonidet P-40) containing a protease inhibitor cocktail
Roche, Mannheim, Germany). The homogenate was centrifuged at 12,000 rpm for 20
inutes at 4°C. The supernatant was decanted from the pellet and used for Western blot
nalyses. The concentration of protein in the homogenate was measured using the
io-Rad Protein Assay Kit I (Bio-Rad, Hercules, California). The homogenates of equal
mounts of protein (50 g) were fractionated using 10% (w/v) SDS-polyacrylamide gel
lectrophoresis and transferred onto a polyvinylidene difluoride membrane. The mem-
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Current Therapeutic Researchbrane was then incubated with antiphospho-NR1 antibody (rabbit immunoaffinity pu-
rified immunoglobulin-G, 1:500, Upstate Biotechnology, Temecula, California) and
monoclonal anti--actin antibody (1:50,000, Sigma, St. Louis, Missouri) for 2 hours at
oom temperature. The blots were washed 3 times for 20 minutes each with a washing
uffer and then incubated with horseradish peroxidase conjugated immunoglobulin-G
1:2000, goat antirabbit, Upstate Biotechnology; 1:2000, donkey antimouse, Amersham
harmacia Biotech, Arlington Heights, Illinois). The blots were exposed to autoradio-
raphic film (Eastman Kodak Co., Rochester, New York); the films were scanned into a
omputer, and the intensity of the immunoreactive bands of interest was quantified using
eta Image series software (Molecular Devices, Downingtown, Pennsylvania). The den-
ity was calculated using the formula: Density  Log (255/Intensity). Using the -actin
as the internal standard, the ratios of the pNR1 to the -actin density were calculated and
compared among the different groups.
Statistical Analysis
All data are expressed as mean (SEM). Mechanical thresholds obtained as previ-
usly described were analyzed by 1-way ANOVA, followed by Dunnet t post hoc test
t each time point. The data from the Western blot analysis were expressed as the
atios of pNR1 density to -actin density. The changes of pNR1 ratio among
ifferent groups were also tested by 1-way ANOVA, followed by Dunnet t post hoc
est. Correlation calculation was performed with Spearman’s correlation analysis. A
value  0.05 was considered significant.
RESULTS
Experiment I: Anti-Allodynic Effect of NAC Over Time
Baseline values for the sham, vehicle, NAC 30, NAC 100, and NAC 300 groups
ere not significantly different. The vehicle-control group developed mechanical
llodynia over a prolonged period in both the ipsilateral and contralateral hind paws,
ith more pronounced effects on the ipsilateral side as previously described.17
Ipsilateral and contralateral mechanical allodynia were present after reperfusion,
peaked at 3 days, and lasted for at least 28 days after reperfusion (P  0.001 from
baseline or sham at all time points).
Compared with vehicle group, pain behavior was attenuated significantly, in a
dose-dependent manner, in the CPIP-induced rats that received the antioxidant
NAC. The pain threshold increased significantly at 3 and 5 days, and 1, 2, 3, and 4
weeks after reperfusion with the 30 mg/kg dose compared with the vehicle group on
the ipsilateral side (P  0.001 at all time points). At 100 mg/kg dose of NAC, the
pain threshold increased significantly at 4 hours; 3 and 5 days; and 1, 2, 3, and 4
weeks after reperfusion (P  0.007 at 4 hours and P  0.001 at other time points),
whereas at 300 mg/kg dose, the effect was observed at 4 hours; 1 3, and 5 days, and 1,
2, 3, and 4 weeks after reperfusion (P  0.005 at 1 day and P  0.001 at other time
points). Significant main effects of group were observed at 4 hours (F3,20  21.6; P 
.001), 1 day (F3,20  9.3; P  0.001), 3 days (F3,20  484.6; P  0.001), 5 days(F3,20 275.5; P 0.001), 1 week (F3,20 176.4; P 0.001), 2 weeks (F3,20 160.0;
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K.-H. Kwak et al.P  0.001), 3 weeks (F3,20  202.3; P  0.001), and 4 weeks (F3,20  139.2; P 
0.001) after reperfusion on the ipsilateral side. The contralateral ameliorative effect of
NAC on mechanical allodynia at 30 mg/kg was significant only at 3 and 5 days, and 1,
2, and 3 weeks (P  0.029 at 2 weeks, P  0.022 at 3 weeks, and P  0.001 at other
time points). However, at 100 mg/kg, the effect was significant at 3 and 5 days, and 1,
2, 3, and 4 weeks after reperfusion (all, P 0.001), whereas at 300 mg/kg dose, the effect
as observed at 4 hours; 1, 3, and 5 days; and 1, 2, 3, and 4 weeks after reperfusion
P  0.012 at 4 hours, P  0.03 at 1 day, and P  0.001 at other time points).
Significant main effects of group were observed at 4 hours (F3,20  6.6; P  0.003), 1
ay (F3,20 3.6; P 0.031), 3 days (F3,20 138.1; P 0.001), 5 days (F3,20 269.0;
P  0.001), 1 week (F3,20  169.3; P  0.001), 2 weeks (F3,20  109.5; P  0.001),
3 weeks (F3,20  99.2; P  0.001), and 4 weeks (F3,20  59.1; P  0.001) after
eperfusion on the contralateral side (Table I).
However, mechanical thresholds for NAC groups were not normalized to the sham
roup (P  0.001 at all time points, except P  0.001 at 3 days on the contralateral
ide in NAC 300) on the ipsilateral and contralateral sides, thus indicating that NAC
reatment did not abolish mechanical allodynia completely, although there was an
nquestionable significant effect of the NAC treatment group compared with the
ehicle group. Significant main effects of group were observed at 4 hours (F3,20 
063.1; P  0.001), 1 day (F3,20  169.7; P  0.031), 3 days (F3,20  379.0; P 
.001), 5 days (F3,20  404.0; P  0.001), 1 week (F3,20  417.0; P  0.001), 2
weeks (F3,20  92.8; P  0.001), 3 weeks (F3,20  273.4; P  0.001), and 4 weeks
(F3,20  68.4; P  0.001) after reperfusion on the ipsilateral side. Significant main
effects of group were observed at 4 hours (F3,20  1031.8; P  0.001), 1 day
(F3,20 567.3; P 0.031), 3 days (F3,20 48.8; P 0.001), 5 days (F3,20 776.2;
P  0.001), 1 week (F3,20  232.8; P  0.001), 2 weeks (F3,20  2173.0; P 
.001), 3 weeks (F3,20  69.6; P  0.001), and 4 weeks (F3,20  89.1; P  0.001)
fter reperfusion on the contralateral side (Table I).
Experiment II: Change in Pain Behavior and the Level of PNR1
Protein After NAC Administration
Baseline values of mechanical thresholds for the sham, vehicle, NAC 30, NAC 100,
nd NAC 300 groups were not significantly different (data not shown). Pain behavior
nd Western blot data measured at 3 days are presented in Figure 1. All NAC
reatment groups showed significant antiallodynic effects relative to the saline-treated
PIP (vehicle) group (F3,20  521.0; P  0.001; all, P  0.001), although
echanical thresholds of NAC groups were not normalized to that of sham (F3,20 
402.1; P 0.001; all, P 0.001). In vehicle rats, the relative levels of pNR1 protein
ere increased approximately 145% compared with sham rats, confirming that the
mount of NMDA receptor phosphorylation was increased significantly in CPIP
europathic rats (P  0.001). The relative density of pNR1 in NAC-treated rats
NAC 30, 100, and 300 mg/kg) decreased significantly in the ipsilateral L4/6 spinal
ord compared with that of the vehicle control group (all, P  0.001). A significant
main effect of group was observed (F3,20  260.7; P  0.001). Compared with that
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Table I. Time course of the effects of N-acetyl-L-cysteine (NAC) on the development of mechanical allodynia in hind paws. Data are
given in mean (SEM).
Ipsilateral 1-Way ANOVA
Time Point Sham Vehicle NAC 30 NAC 100 NAC 300 F* P F† P
Before Ischemia
Baseline 14.50 (0.32) 14.25 (0.34) 13.42 (0.75) 14.50 (0.32) 14.50 (0.32) 1.4 0.281 1.2 0.331
After Reperfusion
4 h 14.50 (0.32) 2.18 (0.41) 2.39 (0.09)‡ 3.23 (0.05)‡§ 4.38 (0.10)‡ 1063.1 0.001 21.6 0.001
1 d 13.67 (0.79) 3.11 (0.34) 2.79 (0.10)‡ 2.97 (0.07)‡ 4.03 (0.07)‡§ 169.7 0.001 9.3 0.001
3 d 14.50 (0.32) 0.71 (0.12) 3.71 (0.10)‡ 7.34 (0.23)‡ 9.78 (0.22)‡ 379.0 0.001 484.6 0.001
5 d 14.75 (0.25) 1.43 (0.21) 3.99 (0.10)‡ 7.16 (0.22)‡ 9.55 (0.29)‡ 404.0 0.001 275.5 0.001
1 wk 14.50 (0.32) 2.00 (0.30) 4.06 (0.12)‡ 6.51 (0.24)‡ 8.51 (0.13)‡ 417.0 0.001 176.4 0.001
2 wk 13.92 (0.82) 1.34 (0.23) 3.76 (0.10)‡ 5.97 (0.25)‡ 7.95 (0.28)‡ 92.8 0.001 160.0 0.001
3 wk 14.25 (0.34) 1.13 (0.16) 3.83 (0.15)‡ 6.31 (0.27)‡ 8.74 (0.28)‡ 273.4 0.001 202.3 0.001
4 wk 13.67 (0.79) 3.16 (0.31) 5.31 (0.12)‡ 7.29 (0.26)‡ 9.78 (0.23)‡ 68.4 0.001 139.2 0.001
Contralateral 1-Way ANOVA
Time Point Sham Vehicle NAC 30 NAC 100 NAC 300 F* P F† P
Before Ischemia
Baseline 14.75 (0.25) 13.67 (0.79) 13.92 (0.82) 14.75 (0.25) 14.50 (0.32) 0.8 0.529 0.7 0.569
After Reperfusion
4 h 14.75 (0.25) 4.72 (0.80) 4.11 (0.09)‡ 5.01 (0.14)‡ 6.58 (0.05)¶‡ 1031.8 0.001 6.6 0.003
1 d 14.50 (0.32) 4.40 (0.67) 4.38 (0.10)‡ 4.60 (0.06)‡ 5.82 (0.23)¶‡ 567.3 0.001 3.6 0.031
3 d 13.67 (0.79) 0.88 (0.04) 4.85 (0.15)‡ 8.25 (0.17)‡ 10.36 (0.67)# 48.8 0.001 138.1 0.001
5 d 15.00 (0.00) 2.19 (0.28) 4.75 (0.12)‡ 8.12 (0.16)‡ 9.78 (0.23)‡ 776.2 0.001 269.0 0.001
1 wk 14.25 (0.33) 2.28 (0.24) 4.93 (0.15)‡ 7.51 (0.22)‡ 9.10 (0.29)‡ 232.8 0.001 169.3 0.001
2 wk 15.00 (0.00) 4.23 (0.49) 5.26 (0.12)¶‡ 8.51 (0.13)‡ 10.01 (0.00)‡ 2173.0 0.001 109.5 0.001
3 wk 14.17 (0.83) 4.32 (0.44) 5.39 (0.03)¶‡ 8.51 (0.13)‡ 9.78 (0.23)‡ 69.6 0.001 99.2 0.001
4 wk 14.50 (0.32) 5.01 (0.19) 5.82 (0.23)‡ 9.55 (0.29)‡ 10.59 (0.58)‡ 89.1 0.001 59.1 0.001
NAC 30  NAC 30 mg/kg treatment (n  6); NAC 100  NAC 100 mg/kg treatment (n  6); NAC 300  NAC 300mg/kg treatment (n  6); Sham (n  6); Vehicle  saline treatment (n  6).
*1-Way ANOVA between the sham and treatment groups (NAC 30, 100, 300); df  3,20.
†1-Way ANOVA between the vehicle and treatment groups (NAC 30, 100, 300); df  3,20.
‡P  0.001 versus the vehicle group.
§P  0.01 versus the vehicle group.
P  0.001 versus the sham group.
¶P  0.05 versus the vehicle group.
#P  0.01 versus the sham group.
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K.-H. Kwak et al.of the sham group, relative density of pNR1 of NAC 300 mg/kg did not differ (P 
.386), whereas the relative density of pNR1 in NAC-treated rats (NAC 30, 100
g/kg) was significantly high (all, P 0.001). A significant main effect of group was
observed (F3,20  324.2; P  0.001).
By Spearman’s correlation analysis, the NAC dose was significantly correlated not
only with paw-withdrawal threshold (  0.979; P  0.001) but also with the
relative density of pNR1 (  –0.875; P  0.001), indicating that NAC contrib-
uted, in a dose-dependent manner, to the analgesic effect and the block of phosphor-
ylation of the NMDA receptor. Importantly, a significant correlation was found
between the paw-withdrawal threshold and the relative density of pNR1 ( 
–0.828; P  0.001; Figure 2).
DISCUSSION
The main finding of this study was that NAC, when administered in a pre-reperfusion
period in CPIP rats, was capable of attenuating IR injury-induced mechanical
allodynia for 4 weeks and attenuating the increase in NMDA-receptor phosphoryla-
tion in the spinal cord. Rats exposed to prolonged IR injury in the hind paw exhibited
Figure 1. The effect of N-acetyl-L-cysteine (NAC) on mechanical allodynia (A) and the
relative density of phosphorylated N-methyl-D-aspartate (NMDA) receptor 1 sub-
unit (pNR1) protein in the spinal cord (L4/6) with an example of Western blot
gel (B) at 3 days after reperfusion. In the left graph (A). all NAC groups showed
significant antiallodynic effects relative to the vehicle group, although mechan-
ical thresholds of NAC groups were not normalized to that of sham. The right
graph (B) represents the pNR1 gel density ratio for each group. The relative
density of pNR1 in all NAC groups decreased significantly compared with that of
the vehicle group, although the relative density of pNR1 in NAC groups (NAC 30,
100 mg/kg) was significantly high compared with that of sham group. The data
are presented as mean (SEM). NAC 30  NAC 30 mg/kg treatment (n  6);
NAC 100  NAC 100 mg/kg treatment (n  6); NAC 300 NAC 300 mg/kg
treatment (n  6); sham rats (n  6); vehicle  saline treatment (n  6). *P <
0.001 versus the vehicle group; †P < 0.001 versus the sham group.acute hyperemia and plasma extravasation, as well as chronic neuropathic pain-like
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Current Therapeutic Researchsymptoms, including mechanical allodynia and hyperalgesia in both the ischemic
and, to a lesser extent, the contralateral hind paw. Prolonged hind limb IR was shown
to produce a well-documented cascade of inflammatory events, with a key role for
ROS, such as superoxide, hydrogen peroxide, and peroxynitrite anions.21 We dem-
onstrated that mechanical allodynia among these symptoms, which are similar to
those in CRPS patients, was attenuated by the administration of NAC, and this
persisted for 4 weeks. The antinociceptive effect of NAC was initially evaluated in the
CPIP model by Coderre et al,17 who reported that NAC alleviated mechanical
llodynia in CPIP rats. This finding was consistent with other findings showing that
AC produced antinociception in the neurogenic phase of the formalin test in mice
nd the capsaicin test.16 These data supported the hypothesis that ROS were involved
n the maintenance of chronic pain.
In contrast, the antinoceptive effect of NAC can be explained through several
xidative pathways. First, NAC treatment might have raised nerve glutathione levels
ecause of its capacity to donate the amino acid cysteine, a component of glutathi-
ne.22 Because glutathione is one of the key defenses against ROS and oxidative stress,
uch as nitric oxide and superoxide within neurons, an increase in its levels might be
rotective.23 Furthermore, at high doses, NAC had direct reductant24 and antioxi-
ant effects and could block lipid peroxidation by peroxinitrate.25 It might have also
scavenged ROS and nitric oxide due to the free sulfhydryl group in NAC.15
Interestingly, we found a long-term antiallodynic effect of NAC injected during the
Figure 2. The relationship between mechanical allodynia (withdrawal threshold) and the
relative density of phosphorylated N-methyl-D-aspartate (NMDA) receptor 1 subunit
(pNR1) protein at 3 days after reperfusion. Rats as a whole showed the significant
inverse relationship between the mechanical withdrawal threshold and the relative
density of pNR1 protein (  –0.828; P < 0.01). NAC 30  NAC 30 mg/kg
treatment (n 6); NAC 100NAC 100 mg/kg treatment (n 6); NAC 300NAC
300 mg/kg treatment (n  6); vehicle  saline treatment (n  6).arly, formative phase of neuropathic pain. Unlike most previous studies, in which
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K.-H. Kwak et al.antioxidants were administered to rats with already developed neuropathic pain, NACwas
administered just at pre-reperfusion, a critical phase of IR injury. This indicated that the
modulation of oxidative stress through NAC administration might involve central sen-
sitization. We confirmed this by demonstrating that NAC attenuated NMDA receptor
phosphorylation in CPIP rats. Clearly, one should be cautious in interpreting animal data,
but these findings might support a rationale for investigating the possible therapeutic use
of NAC as an adjuvant in the treatment of patients with CRPS.
Central sensitization in the spinal cord is defined by an increased responsiveness of
dorsal horn neurons to nociceptive peripheral stimulation.26 Glutamate, a major excit-
atory amino acid, is involved in central sensitization through NMDA receptor activa-
tion.27–29 Activation of NMDA receptors increases intercellular calcium levels, which, in
urn, increases the activity of several free-radical generating enzymes, such as nitric oxide
ynthase.30 To activate NMDA receptors, phosphorylation of NMDA receptors, and more
precisely, the functional subunit of NR1 is essential. Several studies showed that the
amount of pNR1 protein was related to pain behavior in different animal models.13,31 In
the present study, CPIP rats pretreated with NAC showed attenuation of the enhance-
ment of NMDA-receptor phosphorylation, measured by the levels of pNR1 protein in the
spinal cord in conjunction with the alleviation of mechanical allodynia. NAC is a
low-molecular-weight compound that readily passes through the blood–brain barrier and
reaches the spinal cord.32 Thus, systemically injected NAC can reduce central sensitiza-
ion by acting directly on the spinal cord, in addition to peripheral modification of ROS
n the IR injury tissue. However, considering the timing of pre-reperfusion administra-
ion of NAC, profound behavioral effect over a prolonged period of time would be related
ore closely to peripheral contribution of NAC to central sensitization. Thus, by increas-
ng antioxidant defenses through increasing glutathione, NAC might reduce pain trans-
ission and central sensitization.
There were several limitations to this study. First, systemically injected NAC acts
eripherally and centrally. Therefore, additional study with various approaches,
ncluding intrathecal drug injection, is needed to unravel the relative contribution of
oth peripheral and central action of NAC in the modulation of central sensitization.
econd, although the present experimental study was designed to resemble the
linical conditions of CRPS, all such experimental models have important differences
ompared with the setting of CRPS in humans. Additionally, this was a small
xperimental study in a CRPS model in rats; therefore, large and controlled studies
n humans are needed to confirm the results.
CONCLUSIONS
This study demonstrated that ROS scavenger NAC effectively attenuated mechanical
allodynia, and that this antiallodynia was achieved, in part, by inhibiting NMDA
receptor phosphorylation, leading to central sensitization and resulting in decreased
chronic pain in the CPIP rat model. Thus, this study identified oxidative stress as an
important determinant of the neuropathologic and behavioral consequences of IR
injury, providing support for the potential use of NAC as a therapeutic agent in the
treatment of IR injury-related neuropathic pain in CRPS patients.
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